Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia

$Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia$

Journal article

Peer reviewed

Pancreas, Vol.42(4), pp.722-723

2013-05

PMID: 23591434

Abstract

Humans

Middle Aged

Hypoglycemia - drug therapy

Octreotide - therapeutic use

Metformin - adverse effects

Diabetes Mellitus, Type 2 - blood

Female

Hypoglycemia - blood

Blood Glucose - metabolism

Diabetes Mellitus, Type 2 - drug therapy

Hypoglycemia - chemically induced

Glyburide - adverse effects

Hypoglycemic Agents - adverse effects

6 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.287 Dietary Stimulants; 1.287.2011 Lipoid Pneumonia
Web Of Science research areas: Gastroenterology & Hepatology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia
Creators: Jodie A Barkin
Heather M Block
Paul E Mendez
Publication Details: Pancreas, Vol.42(4), pp.722-723
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Gastroenterology; UMMG Dept of Medicine - General Internal Medicine
Language: English
Resource Type: Journal article
PMID: 23591434
Record Identifier: 991031597010902976